Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 470425, 6 pages
http://dx.doi.org/10.1155/2014/470425
Research Article

Prophylactic Efficacy of Melatonin on Cyclophosphamide-Induced Liver Toxicity in Mice

1Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, 18 Kilometers of Farah Abad Road, Sari 48175-861, Iran
2Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, 18 Kilometers of Farah Abad Road, Sari 48175-861, Iran
3Department of Pathology, Faculty of Medicine, Mazandaran University of Medical Sciences, 18 Kilometers of Farah Abad Road, Sari 48175-861, Iran
4Student Research Committee, Mazandaran University of Medical Sciences, 18 Kilometers of Farah Abad Road, Sari 48175-861, Iran

Received 12 February 2014; Accepted 13 June 2014; Published 30 June 2014

Academic Editor: Masood Ahmad

Copyright © 2014 Mohammad Shokrzadeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Dollery, Therapeutic Drugs, Churchill Livingstone, Edinburgh, UK, 1999.
  2. I. D. Capel, M. Jenner, H. M. Dorrell, and D. C. Williams, “Hepatic function assessed (in rats) during chemotherapy with some anti-cancer drugs,” Clinical Chemistry, vol. 25, no. 8, pp. 1381–1383, 1979. View at Google Scholar · View at Scopus
  3. L. H. Fraiser, S. Kanekal, and J. P. Kehrer, “Cyclophosphamide toxicity: characterising and avoiding the problem,” Drugs, vol. 42, no. 5, pp. 781–795, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Honjo, T. Suou, and C. Hirayama, “Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis,” Research Communications in Chemical Pathology and Pharmacology, vol. 61, no. 2, pp. 149–165, 1988. View at Google Scholar · View at Scopus
  5. A. Bhattacharya, R. A. Lawrence, A. Krishnan, K. Zaman, D. Sun, and G. Fernandes, “Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice,” Journal of the American College of Nutrition, vol. 22, no. 5, pp. 388–399, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Stankiewicz, E. Skrzydlewska, and M. Makieła, “Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats,” Drug Metabolism and Drug Interactions, vol. 19, no. 2, pp. 67–82, 2002. View at Google Scholar · View at Scopus
  7. N. I. Weijl, F. J. Cleton, and S. Osanto, “Free radicals and antioxidants in chemotherapy-induced toxicity,” Cancer Treatment Reviews, vol. 23, no. 4, pp. 209–240, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Reiter, “Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review,” Brazilian Journal of Medical and Biological Research, vol. 26, no. 11, pp. 1141–1155, 1993. View at Google Scholar · View at Scopus
  9. R. Reiter, L. Tang, J. J. Garcia, and A. Muñoz-Hoyos, “Pharmacological actions of melatonin in oxygen radical pathophysiology,” Life Sciences, vol. 60, no. 25, pp. 2255–2271, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Cagnoli, C. Atabay, E. Kharlamova, and H. Manev, “Melatonin protects neurons from singlet oxygen-induced apoptosis,” Journal of Pineal Research, vol. 18, no. 4, pp. 222–226, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. K. A. Marshall, R. J. Reiter, B. Poeggeler, O. I. Aruoma, and B. Halliwell, “Evaluation of the antioxidant activity of melatonin in vitro,” Free Radical Biology and Medicine, vol. 21, no. 3, pp. 307–315, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Pieri, M. Marra, F. Moroni, R. Recchioni, and F. Marcheselli, “Melatonin: a peroxyl radical scavenger more effective than vitamin E,” Life Sciences, vol. 55, no. 15, pp. PL271–PL276, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Öner-Iyidogan, F. Gürdöl, and P. Öner, “The effects of acute melatonin and ethanol treatment on antioxidant enzyme activities in rat testes,” Pharmacological Research, vol. 44, no. 2, pp. 89–93, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Sewerynek, R. J. Reiter, D. Melchiorri, G. G. Ortiz, and A. Lewinski, “Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin,” Hepato-Gastroenterology, vol. 43, no. 10, pp. 898–905, 1996. View at Google Scholar · View at Scopus
  15. A. Chabra, M. Shokrzadeh, F. Naghshvar, F. Salehi, and A. Ahmadi, “Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice,” Human & Experimental Toxicology, vol. 33, pp. 185–195, 2014. View at Google Scholar
  16. A. Karamian, M. Shokrzadeh, and A. Ahmadi, The potential chemoprotective effects of melatonin against genotoxicity induced by diazinon in human peripheral blood lymphocytes, Toxicology and Industrial Health, 2013. View at Publisher · View at Google Scholar
  17. R. Bhattacharjee and P. C. Sil, “Protein isolate from the herb Phyllanthus niruri modulates carbon tetrachloride-induced cytotoxicity in hepatocytes,” Toxicology Mechanisms and Methods, vol. 17, no. 1, pp. 41–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Ahmadi, M. A. Ebrahimzadeh, S. Ahmad-Ashrafi, M. Karami, M. R. Mahdavi, and S. S. S. Saravi, “Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists,” Fundamental and Clinical Pharmacology, vol. 25, no. 1, pp. 72–79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. S. Khan, A. Sundin, C. Juhlin, E. Wilander, K. Öberg, and B. Eriksson, “Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer,” Medical Oncology, vol. 21, no. 2, pp. 167–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. B. McDonald, J. T. Slattery, M. E. Bouvier et al., “Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation,” Blood, vol. 101, no. 5, pp. 2043–2048, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Patel, “Stimulation of cyclophosphamide-induced pulmonary microsomal lipid peroxidation by oxygen,” Toxicology, vol. 45, no. 1, pp. 79–91, 1987. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Ahmadi, S. J. Hosseinimehr, F. Naghshvar, E. Hajir, and M. Ghahremani, “Chemoprotective effects of hesperidin against genotoxicity induced by cyclophosphamide in mice bone marrow cells,” Archives of Pharmacal Research, vol. 31, no. 6, pp. 794–797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Hosseinimehr, S. Ahmadashrafi, F. Naghshvar, A. Ahmadi, S. Ehasnalavi, and M. Tanha, “Chemoprotective effects of Zataria multiflora against genotoxicity induced by cyclophosphamide in mice bone marrow cells,” Integrative Cancer Therapies, vol. 9, no. 2, pp. 219–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Chabra, M. Shokrzadeh, F. Naghshvar, F. Salehi, and A. Ahmadi, “Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice,” Human & Experimental Toxicology, 2013. View at Publisher · View at Google Scholar
  25. U. B. Das, M. Mallick, J. M. Debnath, and D. Ghosh, “Protective effect of ascorbic acid on cyclophosphamide-induced testicular gametogenic and androgenic disorders in male rats,” Asian Journal of Andrology, vol. 4, no. 3, pp. 201–207, 2002. View at Google Scholar · View at Scopus
  26. D. Ghosh, U. B. Das, S. Ghosh, M. Mallick, and J. Debnath, “Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: a correlative study with testicular oxidative stress,” Drug and Chemical Toxicology, vol. 25, no. 3, pp. 281–292, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Habibi, M. Shokrzadeh, A. Ahmadi, A. Chabra, F. Naghshvar, and R. Keshavarz-Maleki, “Genoprotective effects of Origanum vulgare ethanolic extract against cyclophosphamide-induced genotoxicity in mice bone marrow cells,” Pharmaceutical Biology. View at Publisher · View at Google Scholar
  28. E. Habibi, M. Shokrzadeh, A. Chabra, F. Naghshvar, R. Keshavarz-Maleki, and A. Ahmadi, “Protective effects of Origanum vulgare L. ethanolic extract against cyclophosphamide-induced liver toxicity in mice,” Pharmaceutical Biology. View at Publisher · View at Google Scholar
  29. M. Shokrzadeh, A. Ahmadi, A. Chabra et al., “An ethanol extract of Origanum vulgare attenuates cyclophosphamide-induced pulmonary injury and oxidative lung damage in mice,” Pharmaceutical Biology, 2014. View at Publisher · View at Google Scholar
  30. M. Shokrzadeh, A. Chabra, A. Ahmadi et al., “Hepatoprotective effects of Zataria multiflora ethanolic extract on liver toxicity induced by cyclophosphamide in mice,” Drug Research, 2014. View at Publisher · View at Google Scholar
  31. R. J. Reiter, T. S. Herman, and M. L. Meltz, “Melatonin and radioprotection from genetic damage: in vivo/in vitro studies with human volunteers,” Mutation Research—Genetic Toxicology, vol. 371, no. 3-4, pp. 221–228, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Shokrzadeh, A. Chabra, F. Naghshvar, A. Ahmadi, M. Jafarinejhad, and Y. Hasani-Nourian, “Protective effects of melatonin against cyclophosphamide-induced oxidative lung toxicity in mice,” Drug Research, 2014. View at Publisher · View at Google Scholar
  33. T. Elkiran, H. Harputluoglu, U. Yasar et al., “Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 29, no. 1, pp. 27–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Selvakumar, C. Prahalathan, Y. Mythili, and P. Varalakshmi, “Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by DL-α-lipoic acid,” Molecular and Cellular Biochemistry, vol. 272, no. 1-2, pp. 179–185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Mathew and G. Kuttan, “Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity,” Journal of Experimental & Clinical Cancer Research, vol. 16, no. 4, pp. 407–411, 1997. View at Google Scholar · View at Scopus
  36. M. Sulkowska, S. Sulkowski, and E. Skrzydlewska, “The effect of pentoxifylline on ultrastructure and antioxidant potential during cyclophosphamide-induced liver injury,” Journal of Submicroscopic Cytology and Pathology, vol. 31, no. 3, pp. 413–422, 1999. View at Google Scholar · View at Scopus
  37. G. B. McDonald and D. Frieze, “A problem-oriented approach to liver disease in oncology patients,” Gut, vol. 57, no. 7, pp. 987–1003, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Senthilkumar, T. Devaki, B. M. Manohar, and M. S. Babu, “Effect of squalene on cyclophosphamide-induced toxicity,” Clinica Chimica Acta, vol. 364, no. 1-2, pp. 335–342, 2006. View at Publisher · View at Google Scholar · View at Scopus